<DOC>
	<DOCNO>NCT00365001</DOCNO>
	<brief_summary>This 2 arm study investigate pharmacokinetics simvastatin methotrexate combination tocilizumab assess potential drug interaction . Patients randomize receive either tocilizumab ( 10mg/kg iv infusion day 8 ) + methotrexate ( 10-25mg po /week ) tocilizumab + methotrexate + simvastatin ( 40mg po day 1 , 15 43 ) . Blood sample take analysis interval day 44 . The anticipated time study treatment &lt; 3 month , target sample size &lt; 100 individual .</brief_summary>
	<brief_title>A Drug Interaction Study Between Tocilizumab , Methotrexate Simvastatin Patients With Rheumatoid Arthritis .</brief_title>
	<detailed_description />
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Arthritis , Rheumatoid</mesh_term>
	<mesh_term>Methotrexate</mesh_term>
	<mesh_term>Simvastatin</mesh_term>
	<criteria>adult patient , 1875 year age ; rheumatoid arthritis &gt; =6 month ; methotrexate &gt; =12 week prior day 1 ( stable 1025mg/week 8 week ) . history , current inflammatory joint disease rheumatic autoimmune disease RA ; concurrent treatment DMARD methotrexate ; prior treatment tocilizumab .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>June 2010</verification_date>
</DOC>